Arlington Capital Partners Acquires Majority Stake in Afton Scientific

Health Care · United States · Undisclosed

Arlington Capital Partners acquired a majority stake in Afton Scientific, a sterile injectable pharmaceutical contract development and manufacturing organization (CDMO). Founder and CEO Tom Thorpe continued in his role as a material shareholder. Deal terms were not disclosed.